Lanxess (LXS) Given a €63.00 Price Target by Goldman Sachs Group Analysts

Share on StockTwits

Goldman Sachs Group set a €63.00 ($73.26) target price on Lanxess (ETR:LXS) in a report published on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Other analysts also recently issued reports about the company. Nord/LB set a €62.00 ($72.09) price target on Lanxess and gave the company a buy rating in a report on Thursday, January 24th. Warburg Research set a €66.80 ($77.67) price target on Lanxess and gave the company a buy rating in a report on Monday, February 11th. JPMorgan Chase & Co. set a €55.00 ($63.95) price target on Lanxess and gave the company a buy rating in a report on Thursday, March 14th. Commerzbank set a €64.00 ($74.42) price target on Lanxess and gave the company a buy rating in a report on Tuesday, March 5th. Finally, HSBC set a €80.00 ($93.02) price objective on shares of Lanxess and gave the company a buy rating in a research report on Wednesday, March 20th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have given a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of €61.72 ($71.76).

Shares of ETR LXS opened at €47.38 ($55.09) on Thursday. Lanxess has a 12-month low of €39.47 ($45.90) and a 12-month high of €72.60 ($84.42). The firm has a market capitalization of $4.20 billion and a P/E ratio of 10.32. The company has a debt-to-equity ratio of 101.71, a current ratio of 2.61 and a quick ratio of 1.53.

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Read More: What is the downside to momentum investing?

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ooma Inc  CFO Sells $64,302.06 in Stock
Ooma Inc CFO Sells $64,302.06 in Stock
Norman Gennaro Sells 752 Shares of Zendesk Inc  Stock
Norman Gennaro Sells 752 Shares of Zendesk Inc Stock
Richard Rappaport Sells 3,000 Shares of Skechers USA Inc  Stock
Richard Rappaport Sells 3,000 Shares of Skechers USA Inc Stock
Sailpoint Technologies Holdings Inc  Director Sells $80,000.00 in Stock
Sailpoint Technologies Holdings Inc Director Sells $80,000.00 in Stock
James Franklin Sells 50,000 Shares of Ur-Energy Inc.  Stock
James Franklin Sells 50,000 Shares of Ur-Energy Inc. Stock
Gordon R. Bernard Sells 8,876 Shares of Cumberland Pharmaceuticals, Inc.  Stock
Gordon R. Bernard Sells 8,876 Shares of Cumberland Pharmaceuticals, Inc. Stock


© 2006-2019 Ticker Report